Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	-	-	-

Company Profile for Akili, Inc. - Common Stock Share

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

Company Data

Name Akili, Inc. - Common Stock

Company Akili, Inc.

Symbol AKLI

Website https://www.akiliinteractive.com

Primary Exchange

NASDAQ

ISIN US00974B1070

Asset Class Share

Sector Healthcare

Industry Medical - Healthcare Information Services

CEO Mr. Matthew Franklin M.B.A.

Market Capitalization 34 Mio

Country United States of America

Currency USD

Employees 0,1 T

Address 125 Broad Street, 02110 Boston

IPO Date 2021-06-30

ID Changes

Date	From	To
22.08.2022	DNAA	AKLI

Ticker Symbols

Name	Symbol
NASDAQ	AKLI

More Shares

Investors who Akili, Inc. - Common Stock hold also have the following shares in their portfolio:

APEX CRITICAL METALS CORP Share

JAPAN GOVERNMENT BOND INDEX FUND - INSTITUTIONAL PLUS JPY ACC ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog